Vitamin D deficiency in childhood obesity is associated with high levels of circulating inflammatory mediators, and low insulin sensitivity

International Journal of Obesity

Volumn 38, Issue 1, 2014, Pages 46-52

  Reyman, M ^a   Verrijn Stuart, A A ^a   Van Summeren, M ^a   Rakhshandehroo, M ^b   Nuboer, R ^c   De Boer, F K ^d   Van Den Ham, H J ^e   Kalkhoven, E ^b   Prakken, B ^a   Schipper, H S ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MEANDER MEDICAL CENTER   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

adipokines; childhood obesity; inflammation; insulin sensitivity; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CATHEPSIN S; CHEMERIN; COMPLEMENT FACTOR D; FATTY ACID BINDING PROTEIN 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MACROPHAGE MIGRATION INHIBITION FACTOR; OSTEOCALCIN; RETINOL BINDING PROTEIN 4; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BODY MASS; CHILD; CHILDHOOD OBESITY; CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE;

ADOLESCENT; BLOOD GLUCOSE; BODY MASS INDEX; CHEMOKINES; CHILD; CLUSTER ANALYSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; MALE; PEDIATRIC OBESITY; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84891836979     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.75     Document Type: Article

References (41)

1. Abrams SA, Coss-Bu JA, Tiosano D. Vitamin D: effects on childhood health and disease. Nat Rev Endocrinol 2013; 9: 162-170.
2. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
3. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Press: Washington, DC, 2011.
4. Olson ML, Maalouf NM, Oden JD, White PC, Hutchison MR. Vitamin D deficiency in obese children and its relationship to glucose homeostasis. J Clin Endocrinol Metab 2012; 97: 279-285.
5. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 2012; 97: 1953-1961.
6. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013; 10: e1001383.
7. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008; 122: 398-417.
8. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics 2009; 124: e362-e370.
9. Pekkinen M, Viljakainen H, Saarnio E, Lamberg-Allardt C, Makitie O. Vitamin D is a major determinant of bone mineral density at school age. PLoS ONE 2012; 7: e40090.
10. Andiran N, Celik N, Akca H, Dogan G. Vitamin D deficiency in children and adolescents. J Clin Res Pediatr Endocrinol 2012; 4: 25-29.
11. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92: 2017-2029.
12. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8: 685-698.
13. Schipper HS, Nuboer R, Prop S, van den Ham HJ, de Boer FK, Kesmir C et al. Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14(\+ \+) monocytes. Diabetologia 2012; 55: 2800-2810.
14. Neyestani TR, Nikooyeh B, Alavi-Majd H, Shariatzadeh N, Kalayi A, Tayebinejad N et al. Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. J Clin Endocrinol Metab 2012; 97: 2005-2011.
15. Schonbeck Y, Talma H, van Dommelen P, Bakker B, Buitendijk SE, Hirasing RA et al. Increase in prevalence of overweight in Dutch children and adolescents: a comparison of nationwide growth studies in 1980, 1997 and 2009. PLoS ONE 2011; 6: e27608.
16. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
17. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D status: United States, 2001-2006. NCHS Data Brief 2011; 59: 1-8.
18. Schwalfenberg GK, Genuis SJ, Hiltz MN. Addressing vitamin D deficiency in Canada: a public health innovation whose time has come. Public Health 2010; 124: 350-359.
19. Fredriks AM, van Buuren S, Fekkes M, Verloove-Vanhorick SP, Wit JM. Are age references for waist circumference, hip circumference and waist-hip ratio in Dutch children useful in clinical practice? Eur J Pediatr 2005; 164: 216-222.
20. Emmen JM, Wielders JP, Boer AK, van den Ouweland JM, Vader HL. The new Roche Vitamin D Total assay: fit for its purpose? Clin Chem Lab Med 2012; 0: 1-4.
21. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 2004; 144: 47-55.
22. Schipper HS, de Jager W, van Dijk ME, Meerding J, Zelissen PM, Adan RA et al. A multiplex immunoassay for human adipokine profiling. Clin Chem 2010; 56: 1320-1328.
23. Team RDC. R: A Language Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2011.
24. Suzuki R, Shimodaira H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 2006; 22: 1540-1542.
25. Mellerio H, Alberti C, Druet C, Capelier F, Mercat I, Josserand E et al. Novel modeling of reference values of cardiovascular risk factors in children aged 7 to 20 years. Pediatrics 2012; 129: e1020-e1029.
26. Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 2011; 54: 1291-1297.
27. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825.
28. Karnchanasorn R, Ou HY, Chiu KC. Plasma 25-hydroxyvitamin D levels are favorably associated with beta-cell function. Pancreas 2012; 41: 863-868.
29. De Las Heras J, Rajakumar K, Lee S, Bacha F, Holick MF, Arslanian SA. 25-Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes Care 2013; e-pub ahead of print 22 January 2013.
30. Lamendola CA, Ariel D, Feldman D, Reaven GM. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am J Clin Nutr 2012; 95: 1055-1059.
31. Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010; 21: 660-667.
32. Matsumoto K, Sera Y, Nakamura H, Ueki Y, Miyake S. Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2002; 55: 131-138.
33. Verrijn Stuart AA, Schipper HS, Tasdelen I, Egan DA, Prakken BJ, Kalkhoven E et al. Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes. J Clin Endocrinol Metab 2012; 97: 463-472.
34. Alvarez-Diaz S, Valle N, Garcia JM, Pena C, Freije JM, Quesada V et al. Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells. J Clin Invest 2009; 119: 2343-2358.
35. Balbin M, Hall A, Grubb A, Mason RW, Lopez-Otin C, Abrahamson M. Structural and functional characterization of two allelic variants of human cystatin D sharing a characteristic inhibition spectrum against mammalian cysteine proteinases. J Biol Chem 1994; 269: 23156-23162.
36. Jobs E, Ingelsson E, Riserus U, Nerpin E, Jobs M, Sundstrom J et al. Association between serumcathepsin S andmortality in older adults. JAMA 2011; 306: 1113-1121.
37. Taleb S, Clement K. Emerging role of cathepsin S in obesity and its associated diseases. Clin Chem Lab Med 2007; 45: 328-332.
38. Stach K, Kalsch AI, Nguyen XD, Elmas E, Kralev S, Lang S et al. 1alpha,25-dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells. Cardiology 2011; 118: 107-115.
39. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001; 107: 1255-1262.
40. Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arteriosclerosis Thrombosis Vasc Biol 2007; 27: 2292-2301.
41. Mitri J, Pittas AG. Diabetes: shining a light: the role of vitamin D in diabetes mellitus. Nature reviews. Endocrinology 2010; 6: 478-480.